Expression and Purification of Tetanus Toxin Fragment C in Escherichia coli BL21(DE3). 2020

Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
School of Life Science and Engineering, Lanzhou University of Technology, Lanzhou 730050, China

Tetanus is an infectious disease caused by Clostridium secreting tetanus toxin in anaerobic environment. The fragment C of Tetanus toxin (TTc) has been widely studied as a candidate vaccine to replace the existing tetanus toxoid vaccine. In this study, we established a simple method to purify recombinant protein TTc with ion-exchange chromatography from Escherichia coli expression systems. The TTc gene sequence was cloned into pET26b (+) vector and transferred to E. coli BL21 (DE3) for expression. The fermentation conditions (IPTG concentration, Induction temperature, Induction time) were optimized to obtain more soluble proteins. The soluble proteins were purified by Anion exchange chromatography and Cation exchange chromatography. The sequence of columns in the purification process was discussed. Finally, the stability of purified TTc protein were determined, the secondary structure of the purified TTc protein was determined by circular dichroism. The molecular weight of the purified TTc protein was determined by liquid chromatograph- mass spectrometer. Furthermore, we verified the immunogenicity of the purified protein in mice. The purity of TTc improved from 34% to 88% after the first anion exchange column, and the final yield of recombinant TTc (purity > 95%) can reach 84.79% after the following cation exchange chromatography. The recombinant TTc had a molecular weight of 51.737 KDa, was stable at 4 °C and weak alkaline environment, was a β-sheet secondary structure, and had strong immunogenicity. The purification method we developed might be an efficient method for the industrial production of tetanus recombinant TTc vaccine.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D013744 Tetanus Toxin Protein synthesized by CLOSTRIDIUM TETANI as a single chain of ~150 kDa with 35% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS. Clostridial Neurotoxin,Clostridium tetani Toxin,Tetanus Toxins,Neurotoxin, Clostridial,Toxin, Clostridium tetani,Toxin, Tetanus,Toxins, Tetanus
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
December 2018, Archives of Razi Institute,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
January 1986, Journal of bacteriology,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
April 2000, Biotechnology and applied biochemistry,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
May 2017, Nucleic acids research,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
August 2017, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
August 2003, Wei sheng wu xue bao = Acta microbiologica Sinica,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
September 2017, Preparative biochemistry & biotechnology,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
January 2019, Advanced biomedical research,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
December 2019, Journal of biotechnology,
Pengdi Chai, and Xiuying Pu, and Jianqiang Li, and Xiaoyu Xia, and Jun Ge, and Amiao Luo, and Hui Su, and Weijie Zhang, and Jianzhong Ma
January 2014, Biotechnology and applied biochemistry,
Copied contents to your clipboard!